What additional review requirements exist if my research involves recombinant DNA (rDNA), potentially pathogenic substances, toxins, or other biohazardous agents?
Additional federal regulations may apply to your research if your research involves recombinant DNA (rDNA), potentially pathogenic substances, toxins, or other biohazardous agents. In order to access the risks related to research involving these materials and to ensure that the proper safety precautions and procedures are in place, protocols utilizing these materials must be reviewed and approved by the DePaul University Institutional Biosafety Committee (IBC). Research projects may be submitted to the IRB and the IBC simultaneously. However, the IRB review and final approval for the research project cannot occur until final IBC approval has been received. The most common type of protocol at DePaul University requiring IBC review and approval is one drawing blood and utilizing the blood for the research, such laboratory testing or manipulations.
